-
-
-
-
-
-
-
Solid Biosciences (SLDB) Tops Q4 EPS by 17c
-
-
-
-
-
-
-
Solid Biosciences (SLDB) Misses Q1 EPS by 59c
-
-
-
-
-
-
-
Solid Biosciences (SLDB) Reports Q1 Loss of $0.61/sh
-
-
-
-
-
-
-
Solid Biosciences Provides Fourth Quarter and Full-Year 2022 Business Update and Financial Results
-
-
-
-
-
-
-
Solid Biosciences (SLDB) Reports Q4; Announces 2-Year Efficacy and Safety Data from the Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001
-
-
-
-
-
-
-
Pre-Open Stock Movers 03/18: (UPST) (TKAT) (SINO) Higher; (TBIO) (CFRX) (RIDE) Lower (more...)
-
-
-
-
-
-
-
Solid Biosciences (SLDB) Tops Q2 EPS by 3c
-
1,222,711 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

